# Papa Johns International Inc: financial statements, quarterly

PZZA · Nasdaq · CIK 901491 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/pzza.md) · [Financials](/companies/pzza/financials.md) · [Filings](/companies/pzza/filings.md) · [Insiders](/companies/pzza/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pzza/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [523](/filings/0001628280-24-045963.md) | [571 d](/filings/0001628280-26-011965.md) | [514](/filings/0001628280-25-023439.md) | [508](/filings/0001628280-25-038569.md) | [507](/filings/0001628280-25-049845.md) | [531 d](/filings/0001628280-26-011965.md) | [518](/filings/0001628280-26-031668.md) | [529](/filings/0001628280-26-053823.md) | [508](/filings/0001628280-25-049845.md) | [498 d](/filings/0001628280-26-011965.md) | [479](/filings/0001628280-26-031668.md) | [482](/filings/0001628280-26-053823.md) |
| Operating income | $m | [31.9](/filings/0001628280-24-045963.md) | [42.6 d](/filings/0001628280-26-011965.md) | [33.7](/filings/0001628280-25-023439.md) | [28.2](/filings/0001628280-25-038569.md) | [65.2](/filings/0001628280-25-049845.md) | [29.5 d](/filings/0001628280-26-011965.md) | [24.0](/filings/0001628280-26-031668.md) | [24.5](/filings/0001628280-26-053823.md) | [16.2](/filings/0001628280-25-049845.md) | [24.5 d](/filings/0001628280-26-011965.md) | [20.8](/filings/0001628280-26-031668.md) | [23.2](/filings/0001628280-26-053823.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.5](/filings/0001628280-24-045963.md) | [4.3 d](/filings/0001628280-26-011965.md) | [7.7](/filings/0001628280-25-023439.md) | [4.8](/filings/0001628280-25-038569.md) | [12.8](/filings/0001628280-25-049845.md) | [4.6 d](/filings/0001628280-26-011965.md) | [4.5](/filings/0001628280-26-031668.md) | [4.2](/filings/0001628280-26-053823.md) | [1.8](/filings/0001628280-25-049845.md) | [5.7 d](/filings/0001628280-26-011965.md) | [4.1](/filings/0001628280-26-031668.md) | [5.0](/filings/0001628280-26-053823.md) |
| Net income | $m | [15.9](/filings/0001628280-24-045963.md) | [26.1 d](/filings/0001628280-26-011965.md) | [14.6](/filings/0001628280-25-023439.md) | [12.2](/filings/0001628280-25-038569.md) | [41.8](/filings/0001628280-25-049845.md) | [14.8 d](/filings/0001628280-26-011965.md) | [9.2](/filings/0001628280-26-031668.md) | [9.5](/filings/0001628280-26-053823.md) | [4.7](/filings/0001628280-25-049845.md) | [7.1 d](/filings/0001628280-26-011965.md) | [7.3](/filings/0001628280-26-031668.md) | [8.5](/filings/0001628280-26-053823.md) |
| Diluted EPS | $ per share | [0.48](/filings/0001628280-24-045963.md) | not reported | [0.44](/filings/0001628280-25-023439.md) | [0.37](/filings/0001628280-25-038569.md) | [1.27](/filings/0001628280-25-049845.md) | not reported | [0.27](/filings/0001628280-26-031668.md) | [0.28](/filings/0001628280-26-053823.md) | [0.13](/filings/0001628280-25-049845.md) | not reported | [0.21](/filings/0001628280-26-031668.md) | [0.24](/filings/0001628280-26-053823.md) |
| Basic EPS | $ per share | [0.49](/filings/0001628280-24-045963.md) | not reported | [0.45](/filings/0001628280-25-023439.md) | [0.37](/filings/0001628280-25-038569.md) | [1.28](/filings/0001628280-25-049845.md) | not reported | [0.28](/filings/0001628280-26-031668.md) | [0.28](/filings/0001628280-26-053823.md) | [0.14](/filings/0001628280-25-049845.md) | not reported | [0.21](/filings/0001628280-26-031668.md) | [0.25](/filings/0001628280-26-053823.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-24) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [37.5](/filings/0001628280-23-036180.md) | [40.6](/filings/0001628280-25-008427.md) | [27.8](/filings/0001628280-24-021948.md) | [24.3](/filings/0001628280-24-035863.md) | [17.6](/filings/0001628280-24-045963.md) | [38.0](/filings/0001628280-26-011965.md) | [44.0](/filings/0001628280-25-023439.md) | [33.3](/filings/0001628280-25-038569.md) | [39.0](/filings/0001628280-25-049845.md) | [34.6](/filings/0001628280-26-011965.md) | not reported | not reported |
| Current assets | $m | [247](/filings/0001628280-23-036180.md) | [231](/filings/0001628280-25-008427.md) | [226](/filings/0001628280-24-021948.md) | [226](/filings/0001628280-24-035863.md) | [216](/filings/0001628280-24-045963.md) | [231](/filings/0001628280-26-011965.md) | [242](/filings/0001628280-25-023439.md) | [239](/filings/0001628280-25-038569.md) | [271](/filings/0001628280-25-049845.md) | [237](/filings/0001628280-26-053823.md) | [240](/filings/0001628280-26-031668.md) | [234](/filings/0001628280-26-053823.md) |
| Total assets | $m | [878](/filings/0001628280-23-036180.md) | [875](/filings/0001628280-25-008427.md) | [847](/filings/0001628280-24-021948.md) | [838](/filings/0001628280-24-035863.md) | [861](/filings/0001628280-24-045963.md) | [889](/filings/0001628280-26-011965.md) | [898](/filings/0001628280-25-023439.md) | [890](/filings/0001628280-25-038569.md) | [884](/filings/0001628280-25-049845.md) | [838](/filings/0001628280-26-053823.md) | [832](/filings/0001628280-26-031668.md) | [805](/filings/0001628280-26-053823.md) |
| Current liabilities | $m | [301](/filings/0001628280-23-036180.md) | [305](/filings/0001628280-25-008427.md) | [283](/filings/0001628280-24-021948.md) | [275](/filings/0001628280-24-035863.md) | [271](/filings/0001628280-24-045963.md) | [278](/filings/0001628280-26-011965.md) | [283](/filings/0001628280-25-023439.md) | [293](/filings/0001628280-25-038569.md) | [311](/filings/0001628280-25-049845.md) | [291](/filings/0001628280-26-053823.md) | [285](/filings/0001628280-26-031668.md) | [283](/filings/0001628280-26-053823.md) |
| Total liabilities | $m | [1,337](/filings/0001628280-23-036180.md) | [1,318](/filings/0001628280-25-008427.md) | [1,293](/filings/0001628280-24-021948.md) | [1,284](/filings/0001628280-24-035863.md) | [1,276](/filings/0001628280-24-045963.md) | [1,302](/filings/0001628280-26-011965.md) | [1,314](/filings/0001628280-25-023439.md) | [1,306](/filings/0001628280-25-038569.md) | [1,308](/filings/0001628280-25-049845.md) | [1,270](/filings/0001628280-26-053823.md) | [1,269](/filings/0001628280-26-031668.md) | [1,246](/filings/0001628280-26-053823.md) |
| Long-term debt | $m | [769](/filings/0001628280-23-036180.md) | [757](/filings/0001628280-25-008427.md) | [761](/filings/0001628280-24-021948.md) | [759](/filings/0001628280-24-035863.md) | [721](/filings/0001628280-24-045963.md) | [742](/filings/0001628280-26-011965.md) | [742](/filings/0001628280-25-023439.md) | [726](/filings/0001628280-25-038569.md) | [727](/filings/0001628280-25-049845.md) | [710](/filings/0001628280-26-053823.md) | [727](/filings/0001628280-26-031668.md) | [715](/filings/0001628280-26-053823.md) |
| Current portion of debt | $m | [14.8](/filings/0001628280-23-036180.md) | [0.0](/filings/0001628280-24-045963.md) | [1.8](/filings/0001628280-24-021948.md) | [2.4](/filings/0001628280-24-035863.md) | [5.7](/filings/0001628280-24-045963.md) | [0.0](/filings/0001628280-26-011965.md) | not reported | not reported | [2.5](/filings/0001628280-25-049845.md) | [5.0](/filings/0001628280-26-053823.md) | [7.8](/filings/0001628280-26-031668.md) | [12.3](/filings/0001628280-26-053823.md) |
| Shareholders' equity | $m | [(475)](/filings/0001628280-23-036180.md) | [(459)](/filings/0001628280-25-008427.md) | [(462)](/filings/0001628280-24-021948.md) | [(462)](/filings/0001628280-24-035863.md) | [(431)](/filings/0001628280-24-045963.md) | [(430)](/filings/0001628280-26-011965.md) | [(432)](/filings/0001628280-25-023439.md) | [(432)](/filings/0001628280-25-038569.md) | [(439)](/filings/0001628280-25-049845.md) | [(445)](/filings/0001628280-26-053823.md) | [(449)](/filings/0001628280-26-031668.md) | [(453)](/filings/0001628280-26-053823.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-24) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [33.2 d](/filings/0001628280-24-045963.md) | [66.1 d](/filings/0001628280-26-011965.md) | [12.0](/filings/0001628280-25-023439.md) | [30.0 d](/filings/0001628280-25-038569.md) | [13.9 d](/filings/0001628280-25-049845.md) | [50.7 d](/filings/0001628280-26-011965.md) | [31.3](/filings/0001628280-26-031668.md) | [35.5 d](/filings/0001628280-26-053823.md) | [39.3 d](/filings/0001628280-25-049845.md) | [19.8 d](/filings/0001628280-26-011965.md) | [7.2](/filings/0001628280-26-031668.md) | [28.6 d](/filings/0001628280-26-053823.md) |
| Capital expenditure | $m | [16.1 d](/filings/0001628280-24-045963.md) | [25.7 d](/filings/0001628280-26-011965.md) | [13.1](/filings/0001628280-25-023439.md) | [16.1 d](/filings/0001628280-25-038569.md) | [17.8 d](/filings/0001628280-25-049845.md) | [25.6 d](/filings/0001628280-26-011965.md) | [12.2](/filings/0001628280-26-031668.md) | [18.1 d](/filings/0001628280-26-053823.md) | [16.7 d](/filings/0001628280-25-049845.md) | [17.7 d](/filings/0001628280-26-011965.md) | [13.5](/filings/0001628280-26-031668.md) | [12.9 d](/filings/0001628280-26-053823.md) |
| Dividends paid | $m | [15.2 d](/filings/0001628280-24-045963.md) | [14.8 d](/filings/0001628280-26-011965.md) | [15.1](/filings/0001628280-25-023439.md) | [15.1 d](/filings/0001628280-25-038569.md) | [15.2 d](/filings/0001628280-25-049845.md) | [15.2 d](/filings/0001628280-26-011965.md) | [15.2](/filings/0001628280-26-031668.md) | [15.3 d](/filings/0001628280-26-053823.md) | [15.3 d](/filings/0001628280-25-049845.md) | [15.3 d](/filings/0001628280-26-011965.md) | [15.3](/filings/0001628280-26-031668.md) | [15.5 d](/filings/0001628280-26-053823.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-045963.md) | [0.0 d](/filings/0001628280-26-011965.md) | [0.0](/filings/0001628280-24-021948.md) | [0.0 d](/filings/0001628280-24-035863.md) | [0.0 d](/filings/0001628280-24-045963.md) | [2.1 d](/filings/0001628280-26-011965.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-25) | Q1 FY2023 (2023-03-26) | Q2 FY2023 (2023-06-25) | Q3 FY2023 (2023-09-24) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [35.4](/filings/0001628280-23-036180.md) | [34.3](/filings/0001628280-24-021948.md) | [32.7](/filings/0001628280-24-035863.md) | [32.8](/filings/0001628280-24-045963.md) | [32.9](/filings/0001628280-25-023439.md) | [32.9](/filings/0001628280-25-038569.md) | [32.9](/filings/0001628280-25-049845.md) | [32.9](/filings/0001628280-26-031668.md) | [33.0](/filings/0001628280-26-053823.md) | [33.0](/filings/0001628280-25-049845.md) | [33.0](/filings/0001628280-26-031668.md) | [33.1](/filings/0001628280-26-053823.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 32,921,687 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-053823.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.